Indeed, constitutive NRF2 activation was detected in almost 50% of MM primary samples and in several MM cell lines and associated to resistance towards proteasome inhibitors (PI), while NRF2 repression was conversely accompanied by upregulation of the ER stress response protein CHOP and restored sensitivity to PI treatment [83]. The gene discussed is DDIT3; the disease is Miyoshi myopathy.